Paul C Potter

Summary

Country: South Africa

Publications

  1. ncbi request reprint Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial
    Paul C Potter
    University of Cape Town Lung Institute, Western Cape, Republic of South Africa
    Ann Allergy Asthma Immunol 95:175-80. 2005
  2. ncbi request reprint Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
    Alexander Kapp
    Department of Dermatology and Allergology, Hannover Medical University, Ricklingerstrasse 5, D 30449 Hannover, Germany
    J Allergy Clin Immunol 110:277-84. 2002
  3. ncbi request reprint Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study
    Kim A Papp
    Probity Medical Research, Hannover Medical University, Waterloo, Ontario, Canada
    J Am Acad Dermatol 52:240-6. 2005
  4. ncbi request reprint Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination
    Kim A Papp
    Probity Medical Research, Waterloo, Ontario, Canada
    J Am Acad Dermatol 52:247-53. 2005

Detail Information

Publications4

  1. ncbi request reprint Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial
    Paul C Potter
    University of Cape Town Lung Institute, Western Cape, Republic of South Africa
    Ann Allergy Asthma Immunol 95:175-80. 2005
    ..Health-related quality of life (HRQL) was also investigated, which is particularly relevant in children because of the effects of rhinitis on learning, social activities, and comorbidity...
  2. ncbi request reprint Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
    Alexander Kapp
    Department of Dermatology and Allergology, Hannover Medical University, Ricklingerstrasse 5, D 30449 Hannover, Germany
    J Allergy Clin Immunol 110:277-84. 2002
    ..In this study we compared early intervention with pimecrolimus cream with treatment with a vehicle control...
  3. ncbi request reprint Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study
    Kim A Papp
    Probity Medical Research, Hannover Medical University, Waterloo, Ontario, Canada
    J Am Acad Dermatol 52:240-6. 2005
    ..Pimecrolimus was applied twice daily at the first signs or symptoms of the disease until clearance. Outcome measures included the incidence of adverse events and the Eczema Area and Severity Index (EASI)...
  4. ncbi request reprint Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination
    Kim A Papp
    Probity Medical Research, Waterloo, Ontario, Canada
    J Am Acad Dermatol 52:247-53. 2005
    ..We investigated whether treatment of atopic dermatitis with pimecrolimus cream 1% in infants affects the development of a normal antibody response to vaccinations...